跳至主要内容
临床试验/CTRI/2019/07/020000
CTRI/2019/07/020000尚未招募不适用

A Comparative Clinical Study On Role Of Jalaukavcharana And Yashtyadi Lepa In Anjananamika With Special Reference To Hordeolum

Rishikul Campus1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年7月14日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To assess the effect of therapy, objectively all signs and symptoms were given scoring depending upon their severity:

研究概览

简要总结

Ayurveda, the most rational and scientific among the ancient systems of medicine, has immense potential to tackle many medical problems*.* Sushruta Samhita has described 76 Netrarogas, out of which 21 are *Vartmagata Vikaras.*Anjananamika is one of the Vartmagata, Raktpradhan and *Shastrakritya (bhedan) sadhya vyadhi.*The clinical features of Anjanamika resemble with an eye disease named as Hordeolum. It is an acute infection (usually Staphylococcal) involving either the glands of Zeis (External Hordeolum) or the Meibomian glands(Internal Hordeolum).Anjananamika is a raktaj vyadhi and for its intervention jalaukavcharana, vidalak and seka is selected as all three help in curing raktaj or rakta-pitta vitiated disorders. In this study, effort is made in the form of use of localised treatment with Jaluakavcharana and Yashtyadi lepa followed by Seka  and to find out a comparatively better alternate for Hordeolum among the both. The study will be intervened under 2 groups – group A ( Jalaukavcharana with Yashtyadi Seka and group B (Vidalaka with Yashtyadi lepa followed by Yashtyadi Seka) and duration of the trial will be of 5 days. The observation of patients will be carried out on day 1, on 3rd day and after completion of trial and after completion follow up will be done for 1 month

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
10.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • patients having signs and symptoms of Anjananamika and External and Internal Hordeolum.

排除标准

  • 未提供

结局指标

主要结局

To assess the effect of therapy, objectively all signs and symptoms were given scoring depending upon their severity:

时间窗: assessment will be done on 1st day ,3rd day and 5th day after trial. overall assessment after 5 days of trial

1-Cured:91-100% relief in signs and symptoms

时间窗: assessment will be done on 1st day ,3rd day and 5th day after trial. overall assessment after 5 days of trial

4-Mild improvement:26-50% relief in signs and symptoms

时间窗: assessment will be done on 1st day ,3rd day and 5th day after trial. overall assessment after 5 days of trial

2-Markedly improvement:76-90% relief in signs and symptoms

时间窗: assessment will be done on 1st day ,3rd day and 5th day after trial. overall assessment after 5 days of trial

3-Moderately improvement:51-75% relief in signs and symptoms

时间窗: assessment will be done on 1st day ,3rd day and 5th day after trial. overall assessment after 5 days of trial

5-Unchanged/no improvement:less than or equal to 25% relief in signs and symptoms

时间窗: assessment will be done on 1st day ,3rd day and 5th day after trial. overall assessment after 5 days of trial

次要结局

  • exacerbation in signs and symptoms(1 month)

研究者

发起方
Rishikul Campus
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验